Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001387131-17-002162
Filing Date
2017-04-20
Accepted
2017-04-20 16:43:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS admp-424b5_041717.htm 424B5 604574
2 GRAPHIC admp424b5001.jpg GRAPHIC 14309
  Complete submission text file 0001387131-17-002162.txt   625516
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-196976 | Film No.: 17773406
SIC: 2834 Pharmaceutical Preparations